Menu
Skin Care and Laser Physicians of Beverly Hills
About Products Resources Videos Blog
Menu
310.246.0495 Los Angeles, CA

Derek H. Jones CV

Related Pages

NAME

Derek Hunter Jones, MD

BOARD CERTIFICATION

Diplomate, American Board of Dermatology, 1997
Recertified, American Board of Dermatology, 2008 and 2018

EDUCATION

Baylor College of Medicine, Houston, Texas
Doctor of Medicine, May 1993

Tufts University, Medford, Massachusetts
Bachelor of Science, with high honors, Biology/Psychology, May 1987

TRAINING

Columbia College of Physicians and Surgeons, New York, New York
Chief Resident in Dermatology, July 1995 - June 1997;
Resident in Dermatology, July 1994 - June 1995

Baylor College of Medicine Affiliated Hospitals, Houston, Texas
Internship in Internal Medicine, July 1993 - June 1994

PROFESSIONAL PRACTICE

Founder and Director, Skin Care and Laser Physicians of Beverly Hills, 1997 - Present.

ACADEMIC APPOINTMENT

Clinical Associate Professor in Medicine, Dermatology Division
David Geffen School of Medicine, University of California at Los Angeles 1997-2017

Director, American Society for Dermatologic Surgery Cosmetic
Fellowship 2015-present

MEMBERSHIPS, BOARDS and COMMITTEES

Dermatologic Surgery Journal: Assistant Editor, 2016-present.
American Society for Dermatologic Surgery: Board of Directors, 2014-present.
American Society for Dermatologic Surgery: Numerous leadership positions in the fields of post-graduate education, product development, new technologies, industry relations, and mentoring. 2004-present
Editorial Board, Journal of Cosmetic and Laser Therapy, 2006- present.
Editorial Board, Dermatologic Surgery , 2010- 2016.
Fellow, American Society for Dermatologic Surgery, 1999- present.
Fellow, American Academy of Dermatology, 1999- present.

PUBLICATIONS- (Total publications as of March 24, 2018-109)
TABLE OF CONTENTS

Fillers- (1-71)
Botox- (72-85)
Kybella- (86-92)
Male- (93-95)
Laser- (96-102)
Cosmetic- (103)
General Dermatology- (104-109)

    Fillers:

  1. Jones D, Bacigalupi R, Beleznay K. Injectable Soft Tissue Augmentation. In Dermatology, Fourth Addition, Volume Two. Bolognia J, Schaffer J, Cerroni L, Editors. Elsevier, 2018.
  2. Jones D, Hardas B, Murphy D, Temple Relation. In Procedures in Cosmetic Dermatology, Soft Tissue Augmentation Fourth Edition. Carruthers A, Carruthers J, Editors. Elsevier, 2018.
  3. Jones D, Murphy D. Volumizing Hyaluronic Acid Filler for Midface Volume Deficit: 2 year Results from a Pivotal Single-Blind Randomized Controlled Study. Dermatologic Surgery. 2013;39 (11): 1602-11. (This was the FDA approval study for Voluma)
  4. Jones D. Mid-Face Volumizing with Calcium Hydroxylapatite. Journal of Drugs in Dermatology 2012; Volume 11: s31-s32
  5. Jones D. Collyer J, Injectable Fillers for augmentation of the Cheeks and Nasolabial Folds. In Total Esthetic Approach to Clinical Face and Body Rejuvenation. Kim J, Lask G, Neison A, Editors. Informa Healthcare, 2012.
  6. Jones D. Volumizing the Face with Soft Tissue Fillers. Clinics in Plastic Surgery: Cosmetic Medicine and Minimally Invasive Surgery 2011; 38:3, p 379-390.
  7. Jones D. New Option for Facial Volume: Volumizing with a 20mg/mL Smooth, Highly Cohesive, Viscous Hyaluronic Acid Filler and Its Role in Facial Rejuvenation Therapy. Dermatologic Surgery 2010;36:1893-1894.
  8. Jones D, Flynn T. Hyaluronic acids: Clinical Applications. In Injectable Fillers: Principles and Practice, Derek Jones, MD, Editor. Wiley-Blackwell, 2010.
  9. Jones D. Textbook Editor: Injectable Fillers: Principles and Practice. Wiley-Blackwell, 2010. (NOTE---EDITOR OF TEXTBOOK)
  10. Jones D, Saghari S. Collagen based fillers. In Office Cosmetic Procedures- A Practical Manual. Eremia S, Editor. Cambridge University Press, 2010.
  11. Jones D. Semi-permanent and Permanent Fillers. Dermatologic Clinics, Volume 27 (4), October, 2009.
  12. Jones D. Commentary on Improvement of nasolabial fold correction with non-animal stabilized hyaluronic acid (NASHA) 100,000 gel particles/mL filler on 2 retreatment schedules. Dermatologic Surgery, 2008; 34:S1, p S8.
  13. Black J, Jones D. Cohesive Polydensified Matrix Hyaluronic Acid for the Treatment of Etched-in Fine Facial Lines: A 6-Month, Open-Label Clinical Trial. Dermatologic Surgery, IN PRESS.
  14. Shumate G, Chopra R, Jones D, et al. In Vivo Degradation of Crosslinked Hyaluronic Acid Fillers by Exogenous Hyaluronidases. Dermatologic Surgery, IN PRESS.
  15. Jones D. Soft Tissue Augmentation. In Goldberg D (Editor), Facial Rejuvenation, a Total Approach; Springer 2007.
  16. Jones D. Facial Lipoatrophy: Etiology and Methods of Correction. Tissue Augmentation in Clinical Practice 2nd Edition. Arnold Klein, Editor (2006). New York, NY: Taylor and Francis Group.
  17. Jones D. Approaches to Treatment of Facial Lipoatropy. Skin Therapy Letter, J Dover and M Alam, Eds. 2005; Vol 10 (9).
  18. Shumate G, et al, Jones D, et al. In Vivo Degradation of Crosslinked Hyaluronic Acid Fillers by Exogenous Hyaluronidases. Journal of Dermatologic Surgery. IN PRESS.
  19. Breithaupt A, Jones D, Braz A, Narins R, Weinkle S. Anatomical Basis for Safe and Effective Volumization of the Temple. Journal of Dermatologic Surgery 2015; 41(125): S278-S283.
  20. Saedi N, Rotunda A, Jones D, Narins R, Matarasso S. Soft Tissue Augmentation. Volume Two Third Edition Dermatology Edited by Bolognia J, Jorizzo J, Schaffer J. 2012; 2547-2560.
  21. Narins R, Donofrio L, Rubin M, Jones D. Guest Editors, Special issue on Fillers. Dermatologic Surgery Part II; 2012
  22. Narins R, Coleman W, Donofrio L, Jones D, Maas C, Monheit G, Kaur M, Grundy S, Pappert E, Hardas B. Improvement in Nasolabial Folds with Hyaluronic Acid Filler Using a Cohesive Polydensified Matrix Technology: Results from an 18-Month Open-Label Extension Trial. Dermatologic Surgery 2010;36:1800-1808 (NOTE, THE WAS THE FDA APPROVAL TRIAL FOR BELOTERO)
  23. Smith S, Jones D, Thomas J. Duration of wrinkle correction following repeat treatment with Juvederm hyaluronic acid fillers. Arch Dermatol Res 2010; 302 (10): 757-762.
  24. Flynn TC, Jones D: "Fillers and fat transfer for treatment of acne scarring," in Tosti, De Padova, Beer (eds): Acne Scars. London, Informa Healthcare, Chapter 8, pp 49-56, 2010.
  25. Beynet D, Jones D, Flynn T. Fillers and Botulinum Toxin in Facial Resurfacing. In Facial Resurfacing, Goldberg D, Editor. Wiley Blackwell, 2010.
  26. Narins R, Coleman W, Donofrio L, Jones D, Mass C, Monheit G, Kuar M, Grundy SL, Pappert EJ, Hardas B. Nonanimal Sourced Hyaluronic Acid-Based Dermal Filler Using a Polydensified Matrix Technology is Superior to Bovine Collagen in the Correction of Moderate to Severe Nasolabial Folds: Results from a 6-Month, Randomized, Blinded, Controlled, Multicenter Study. Dermatologic Surgery; Volume 36 (s1): 730-740, April 2010.
  27. Jones D, Donofrio L, Hardas B, et al. Development and Validation of a Photonumeric Scale for Evaluation of Volume Deficit of the Hand. Journal of Dermatologic Surgery 2016; 42: 195-202.
  28. Jones D, Carruthers A, Hardas B, et al. Development of a Photonumeric Scale for Evaluation of Transverse Neck Lines. Journal of Dermatologic Surgery 2016; 42: 235-241.
  29. Jones D. Liquid Injectable Silicone for the Upper Third of the Face. In Pearls and Pitfalls in Cosmetic Oculoplastic Surgery, Second Edition. Hartstein M, Massry G, Holds J, eds. Springer, 2015; 487-489.
  30. Jones D. Treatment of Delayed Reactions to Dermal Fillers. Journal of Dermatologic Surgery 2014; 40(11): 1180.
  31. Jones D, Brody H. Liquid Injectable Silicone. Soft Tissue Augmentation; 3rd Edition Procedures in Cosmetic Dermatology; Edited by Dover S, Alam M, Carruthers J, Carruthers A: 2012; 62-69.
  32. Jones D. Leveling the Playing Field with Comparative Evidence: Which Hyaluronic Acid Filler Has Superior Efficacy, Safety, and Durability?. (Commentary on A prospective, Split-Face, Randomized, Comparative Study of Safety and 12-Month Longevity of Three Formulations of Hyaluronic Acid Dermal Filler for Treatment of Nasolabial Folds.) Dermatologic Surgery 2012; 1151-1152.
  33. Jones D. Treatment of HIV Associated Facial Lipoatrophy: 2012 Update. (Commentary on Injectable Poly-L-Latic Acid for Human Immunodeficiency Virus-Associated Facial Lipoatrophy: Cumulative Year 2 Interim Analysis of an Open-Label Study). Dermatologic Surgery 2012; 1206-1207.
  34. Jones D. Liquid Injectable Silicone and Polymethylmethacrylate. In Dermatologic Surgery-Step by Step, Nouri K, Editor. Wiley-Blackwell, 2010.
  35. Jones D. What Lies Beneath. Dermatologic Surgery 2011; 37:3, p 387-388.
  36. Jones D. Are Aesthetic Grading Scales only a Research Tool?. Dermatologic Surgery 2010;36:1817-1818.
  37. Jones D. Permanent Fillers. In Cosmetic Bootcamp Primer, Beer K, Lupo M, Narukar V, Editors. Informa UK Limited, 2010.
  38. Jones D, Tezel A, Borell M. In-Vitro Resistance to Degradation of HA by Ovine Testicular Hyaluronidase. Dermatologic Surgery; Volume 36 (s1): 804-809, April 2010.
  39. Jones D. Liquid Inejctable Silicone for the Upper Third of the Face. In Pearls and Pitfalls in Cosmetic Oculoplastic Surgery. Hartstein M, Holds J, Massry G, Sengleman R, eds. Springer, 2009.
  40. Jones D. Commentary on Evaluation of Injectable CaHA for the treatment of HIV-Associated Facial Lipoatrophy. Dermatologic Surgery 2008; 34:11; 1498-1499.
  41. Jones D. Commentary on Accurate and Anatomic Midface Filler Injection by Using Cheek Implants as an Injection Template. Dermatologic Surgery, 2008; 34(1), p 96.
  42. Jones D. Late appearing abscesses after Bio-Alcamid Injections for HIV-associated facial lipoatrophy. Dermatologic Surgery, 2007; 33(s2): S193-198.
  43. Jones D, Vleggaar D. Technique for Injecting Poly-L-lactic acid. Journal of Drugs in Dermatology, 2007; 6(1) Supplement: s13-s17.
  44. Jones D. HIV Facial Lipoatrophy: Causes and Treatment. Dermatologic Surgery, 2005; 31:11 (part 2): 1519-1529.
  45. Jones D, Carruthers A, Orentreich D, Brody H, et al. Highly Purified 1000 cs Silicone Oil for Treatment of HIV-associated Facial Lipoatrophy: An Open Pilot Trial. Dermatologic Surgery 2004; 30:1279-1286.
  46. Jones, D. Liquid Injectable Silicone. Dialogues in Dermatology. American Academy of Dermatology, Nov, 2003.
  47. Jones D. Injectable Silicone for Facial Lipoatrophy. Cosmetic Dermatology 2002: 15:13-15.
  48. Jones D. Commentary on HIV Lipodystrophy: Review of the Syndrome and Report of a Case, by M. Chastain et al; Dermatologic Surgery (2001; 27:497-500).
  49. Black J, Jones D. Cohesive Polydensified Matrix Hyaluronic Acid for the Treatment of Etched-in Fine Facial Lines: A 6-Month, Open-Label Clinical Trial. IN PRESS.
  50. 104. Hausauer A, Jones D. Longterm Correction of Iatrogenic Lipoatrophy with Volumizing Hyaluronic Acid Filler. Journal of Dermatologic Surgery. IN PRESS.
  51. Beleznay K, Jones D. Vascular Compromise. In Procedures in Cosmetic Dermatology, Soft Tissue Augmentation Fourth Edition. Carruthers A, Carruthers J, Editors. Elsevier, 2018.
  52. Niforos F, et al, Jones D, et al. Creation and Validation of a Photonumberic Scale to Assess Volume Deficiency in the Infraorbital Region. Journal of Dermatologic Surgery 2017; 43: 684-691.
  53. Waldman A. et al, Jones D et al. ASDS Cosmetic Surgery Fellowship Milestones. Journal of Dermatologic Surgery 2016; 42: 1164-1173.
  54. Sykes J, Carruthers A, Jones D, et al. Development and Validation of a Photonumeric Scale for Assessment of Chin Retrusion. Journal of Dermatologic Surgery 2016; 42: 211-218.
  55. Carruthers A, Jones D, Hardas B, et al. Development and Validation of a Photonumeric Scale for Evaluation of Volume Deficit of the Temple. Journal of Dermatologic Surgery 2016; 42: 203-210.
  56. Donofrio L, Carruthers J, Jones D, et al. Development and Validation of a Photonumeric Scale for Evaluation of Infraorbital Hollows. Journal of Dermatologic Surgery 2016; 42: 251-258.
  57. Black J, Pavicic P, Jones D. Tempering Patient Expectations and Working with Budgetary Constraints when it comes to a Single Versus a Multimodal Approach. Journal of Dermatologic Surgery 2016; 42: 161-164.
  58. Beleznay K, Carruthers J, Humphrey S, Jones D. Avoiding and Treating Blindness From Fillers: A Review of the World Literature. Journal of Dermatologic Surgery 2015; 41(10): 1097-1118.
  59. Sattler G, Carruthers A, Carruthers J, Flynn T, Geister T, Gortelmeyer R, Hardas B, Himmrich S, Jones D, Kerscher M, Mobrmann C, Narins R, Pooth R, Ryzany B, Buchner L, Benter U, Breitscheidel L, Mario M. Validated Assessment Scale for the Neck Volume. Dermatologic Surgery 2012; 343-350.
  60. Rzany R, Carruthers A, Carruthers J, Flynn T, Geister T, Gortelmeyer R, Hardas B, Himmrich S, Jones D, Mario M, Mobrmann C, Narins R, Pooth R, Sattler G, Buchner L, Merito M, Fey C, Kerscher M. Validated Composite Assessment Scales for the Global Face. Dermatologic Surgery 2012; 294-308.
  61. Carruthers J, Flynn T, Geister T, Gortelmeyer R, Hardas B, Himmrich S, Jones D, Kerscher M, Maio M, Mohrmann C, Narins R, Pooth R, Rzany B, Sattler G, Buchner L, Benter U, Breitscheidel L, Carruthers A. Validated Assessment Scales for the Lower Face. Dermatologic Surgery 2012; 38 p 333-342.
  62. Carruthers J, Flynn T, Geister T, Gortelmeyer R, Hardas B, Himmrich S, Jones D, Kerscher M, Maio M, Mohrmann C, Narins R, Pooth R, Rzany B, Sattler G, Buchner L, Benter U, Breitscheidel L, Carruthers A. Validated Assessment Scales for the Mid Face. Dermatologic Surgery 2012; 38 p 320-332.
  63. Sadick N, Prather C, Jones D. Silicone. In Augmentation Fillers. Sadick N, Editor. Cambridge University Press 2010.
  64. Carruthers A, Carruthers J, Hardas B, Jones D, et al. A Validated Hand-Grading Scale. Dermatologic Surgery 2008; 33(s2): s179-183.
  65. Carruthers A, Carruthers J, Hardas B, Jones D, et al. A Validated Rating Scale for Marionette Lines. Dermatologic Surgery; 2008; 33(s2); s167-172.
  66. Carruthers A, Carruthers J, Hardas B, Jones D, et al. A Validated Brow Positioning Grading Scale. Dermatologic Surgery 2008; 33(s2); s150-154.
  67. Carruthers A, Carruthers J, Hardas B, Jones D, et al. A Validated Lip Fullness Rating Scale. Dermatologic Surgery 2008; 33(s2); s161-166.
  68. Prather C, Jones D. Liquid Injectable Silicone. In Carruthers A, Carruthers J (Editors). Procedures in Cosmetic Dermatology: Soft Tissue Augmentation, 2nd Edition, Elsevier-Saunders, 2007.
  69. Prather C, Jones D. Liquid Injectable Silicone for Soft Tissue Augmentation. Dermatologic Therapy, 2006; 19(3):159-168.
  70. Wildemore J, Jones D. Persistent Granulomatous Inflammatory Response Induced by Poly-L-lactic Acid for HIV lipoatrophy. Dermatologic Surgery, 2006; 32:1407-1409.
  71. Orentreich D, Jones D. Liquid Injectable Silicone. In Carruthers A, Carruthers J (Editors). Procedures in Cosmetic Dermatology: Soft Tissue Augmentation, Elsevier-Saunders, 2005.

    72. Botox:

  72. Jones D, Neuromodulators. In Rejuvenation of the Aging Face; Edited by Karam A, Goldman M. JP Medical Publishers, 2015.
  73. Jones D, Carruthers J, Narins R, Coleman W, et al. Efficacy of Incobotulinum toxin A for Treatment of Glabellar Frown Lines: A Post-Hoc Pooled Analysis of Two Randomized, Placebo-Controlled, Phase III Trials. Dermatologic Surgery 2014; 40(7): 776-785. BOTOX (FDA approval trial for Xeomin)
  74. Jones D. Gentleman Relax. Commentary on Botulinum Toxin in Men: A review of Relevant Anatomy and Clinical Trial Data. Dermatologic Surgery 2013; 39 (10): 1444-45.
  75. Jones D, Wesley N. Glabella. Botulinum Toxin; 3rd Edition Procedures in Cosmetic Dermatology; Edited by Dover S, Alam M, Carruthers J, Carruthers A: 2012; 77-84.
  76. Wesley N, Black J, Jones D. Glabella. In Procedures in Cosmetic Dermatology, Botulinum Toxin Fourth Edition. Carruthers A, Carruthers J, Editors. Elsevier, 2018.
  77. Kane M, Gold M, Coleman W, Jones D, et al. A Randomized, Double-Blind Trial to Investigate the Equivalence of IncobotulinumtoxinA and OnabotulinumtoxinA for Glabellar Frown Lines. Journal of Dermatologic Surgery 2015; 41(11): 1310-1319.
  78. Kane M, Cox S, Jones D, Lei X, Gallagher J. Heterogeneity of Crow's Feet Line Patterns in Clinical Trial Subjects. Journal of Dermatologic Surgery 2015; 41(4): 447-456.
  79. Moers-Carpi M, Carruthers J, Fagien S, Lupo M, Delmar H, Jones D, Somogyi C, Lee E, Lei X, MacKinnon S, Beddingfield F. Efficacy and Safety of Onabotulinum toxin A for Treating Crow's Feet Lines Alone or in Combination With Glabellar Lines: A Multicenter, Radomized, Controlled Trial. Journal of Dermatologic Surgery 2014; 40(11): 1181-1190.
  80. Carruthers A, Carruthers J, Coleman W, Donofrio L, Flynn T, Gold M, Heinz M, Harrington L, Jones D, McDaniel D, Rohrer T, Schlobe A, Solish N, Weiss R. Multicenter, Randomized, Phase III Study of a Single Dose of IncobotulinumtoxinA, Free from Complexing Proteins, in the Treatment of Glabellar Frown Lines. Dermatologic Surgery 2013; 39, 551-558 (This was the FDA approval trial for Xeomin)
  81. Carruthers A, Donofrio L, Jones D, et al. Development and Validation of a Photonumeric Scale for Evaluation of Static Horizontal Forehead Lines. Journal of Dermatologic Surgery 2016; 42: 243-250.
  82. Scali C, Humphrey S, Jones D, Carruthers A. Treatment of Posterior Cheek Enlargement in HIV+ Patients with Botulinum Toxin A. Dermatologic Surgery 2013; 39 (9):1407-10.
  83. Carruthers J, Flynn T, Geister T, Gortelmeyer R, Hardas B, Himmrich S, Jones D, Kerscher M, Maio M, Mohrmann C, Narins R, Pooth R, Rzany B, Sattler G, Buchner L, Benter U, Breitscheidel L, Carruthers A. Validated Assessment Scales for the Upper Face. Dermatologic Surgery 2012; 38 p 309-319.
  84. Carruthers A, Carruthers J, Hardas B, Jones D, et al. A Validated Rating Scale for Crow's Feet . Dermatologic Surgery 2008; 33(s2): s173-178.
  85. Carruthers A, Carruthers J, Hardas B, Jones D, et al. A Validated Rating Scale for Forehead Lines. Dermatologic Surgery 2008; 33(s2): s155-160.

    86. Kybella:

  86. Dayan S, et al, Jones D, et al. Efficacy and Safety of ATX-101 by Treatment Session: Pooled Analysis of Data From the Phase 3 REFINE Trials. Aesthetic Surgery Journal, sjy008, https://doi.org/10.1093/asj/sjy008
  87. Jones D, Kenkel J, et al. Proper Technique for Administration of ATX-101 (Deoxycholic Acid Injection): Insights From an Injection Practicum and Roundtable Discussion. Journal of Dermatologic Surgery 2016; 42: 275-281.
  88. Jones D, Carruthers J, Joseph J, et al. REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction. Journal of Dermatologic Surgery 2016; 42: 38-49.
  89. Dayan S, Humphrey S, Jones D, et al. Overview of ATX-101 (Deoxycholic Acid Injection): A Nonsurgical Approach for Reduction of Submental Fat. Journal of Dermatologic Surgery 2016; 42: 263-270.
  90. Kenkel J, Jones D, et al. Anatomy of the Cervicomental Region: Insights From an Anatomy Laboratory and Roundtable Discussion. Journal of Dermatologic Surgery 2016; 42: 282-287.
  91. Faigien S, McChesney P, Jones D, et al. Prevention and Management of Injection-Related Adverse Effects in Facial Aesthetics: Considerations for ATX-101 (Deoxycholic Acid Injection) Treatment. Journal of Dermatologic Surgery 2016; 42: 300-304.
  92. Rotunda A, Jones D. HIV-Associated Lipohypertrophy (buccal fat pad lipoma-like lesions) reduced with Subcutaneously Injected Sodium Deoxycholate. Dermatologic Surgery 2010; 36(8):1348-1354.

    93. Male:

  93. Keaney T, et al, Jones D, et al. The Male Aesthetic Patient: Facial Anatomy, Concepts of Attractiveness, and Treatment Patterns. Journal of Drugs in Dermatology 2018; 17(I): 19-28.
  94. Jones D, Kerscher M, et al. Efficacy of IncobotulinumtoxinA for the Treatment of Glabellar Frown Lines in Male Subjects: Post-Hoc Analyses From Randomized, Double-Blind Pivotal Studies. Journal of Dermatologic Surgery 2017; 43: S235-S241.
  95. Rossi A, Eviatar J, Jones D, et al. Signs of Facial Aging in Men in a Diverse, Multinational Study: Timing and Preventive Behavior. Journal of Dermatologic Surgery 2017; 43: S210-S220.

    96. Laser:

  96. Massey R, Jones D, Diamond J, Eliezri Y, Katz B. The importance of patient selection in CO2 laser skin resurfacing. Cosmetic Dermatology 1997; 10 (2): 10-14.
  97. Carruthers J, Donofrio L, Jones D, et al. Development and Validation of a Photonumeric Scale for Evaluation of Facial Fine Lines. Journal of Dermatologic Surgery 2016; 42: 227-234.
  98. Donofrio L, Carruthers A, Jones D, et al. Development and Validation of a Photonumeric Scale for Evaluation of Facial Skin Texture. Journal of Dermatologic Surgery 2016; 42: 219-226.
  99. Dozier SE, Diven DG, Jones D, Brysk M, Sanchez RL, Motamedi M. The Q-Switched Alexandrite Laser's Effects on Tattoos in Guinea Pigs and Harvested Human Skin. Dermatol Surg 1995; 21: 237-240.
  100. Jones D. Enhanced Eyelashes: Prescription and Over the Counter Options. Aesthetic Plastic Surgery 2011; 35 (1): 116-121.
  101. Carruthers J, Beer K, Jones D, et al. Bimatoprost 0.03% for the Treatment of Eyebrow Hypotrichosis. Journal of Dermatologic Surgery 2016; 42: 608-617.
  102. Glaser D, Jones D, Carruthers J, Largent J, Caulkins C. Epidemiologic Analysis of Eyelash Characteristics with Increasing Age in a Population of Healthy Women. Journal of Dermatologic Surgery 2014; 40(11): 1208-1213.

    103. Cosmetic Dermatology:

  103. Jones D. What's New in Cosmetic Dermatology: 1998. Skin and Aging 1998; 6 (12).

    104. General Dermatology:

  104. Jones D. HIV Dermatology 2000. SearchLight, AIDS Research All., Winter 2000.
  105. Jones D, Beltrani V. Mucous membrane contact dermatitis. Immunology and Allergy Clinics of North America 1997; 17(3): 471-485.
  106. Jones D, Grossman M. Dilantin-like hypersensitivity associated with lamotrigine. J Am Acad Dermatol 1997; 36: 1016-1018.
  107. Jones D, Kay M, Craigen W, MaCabe E, Hawkins H, Dominey A. Coal black hyperpigmentation at birth in a child with congenital adrenal hypoplasia. J Am Acad Dermatol 1995: 323-326.
  108. Jones D, Levy ML. Cutaneous Manifestations of Pediatric Human Immunodeficiency Virus Syndrome and Minor Sexually Transmitted Diseases. Seminars in Pediatric Infectious Diseases 1993; 4(3): 199-201.
  109. DeLeo VA, Altman E, Christiani A, Jones D, Michael E, Perez M, Reichel M, Tok J: Structure, Function, and Immunology of the Skin. Allergy: Principles and Practice. 5th edition, Mosby: St. Louis, 1998.

RESEARCH

  1. Lead Investigator, Investigator for FDA approval on VOLUMA™ for treatment of age related midface lipoatrophy. Allergan. 2007-2013.
  2. Lead Investigator, Phase 3 study of KYBELLA (sodium deoxycholate injection) versus placebo for the reduction of localized subcutaneous fat in the submental area. Kythera. 2012- 2014
  3. Lead Investigator, Investigator Initiated Trial on Combination of Botox Cosmetic and Juvederm Ultra for Brow Enhancement. 2010-2011.
  4. Principal Investigator, Investigator for FDA approval on a new family of Juvederm™. Allergan. 2004-2006
  5. Principal Investigator, Investigator for FDA approval on BELOTERO Soft™ for treatment of mild nasolabial folds. Merz Pharmaceuticals 2008
  6. Principal Investigator, Investigator for FDA approval on a new hyaluronic acid filler BELOTERO™. Merz Pharmaceuticals. 2006-2008
  7. Principal Investigator, Investigator for FDA approval on XEOMIN for treatment of glabellar furrows. Merz Pharmaceuticals. 2008-2011.
  8. Principal Investigator, Study to investigate the equivalence of Xeomin to Botox in the treatment of glabellar frown lines. Merz Pharmaceuticals. 2013-2014
  9. Principal Investigator, Study of ATX-101 for the reduction of localized subcutaneous fat in the submental area in subjects with clinician reported submental fat rating scale grade 1 or grade 4. Kythera. 2013-2015
  10. Principal Investigator, FDA approval on Latisse solution for eyelash growth. Allergan. 2007-2008
  11. Principal Investigator, FDA approval for Juvederm™ for perioral and lip rejuvenation. Allergan. 2007-2008
  12. Principle Investigator, FDA approval of Restylane Refyne. Galderma. 2010.
  13. Principle Investigator, Study of LIPO-202 (salmeterol xinafoate (SX)) versus placebo for the reduction of localized subcutaneous fat in the abdomen area. Lithera. 2013- 2014
  14. Principal Investigator, Study of Latisse versus placebo for eyebrow growth. Allergan. 2013- 2014
  15. Principal Investigator, Study of efficacy of DWP-450 for treatment of moderate-to-severe glabellar lines. Evolus. June 2014-September 2016
  16. Principal Investigator, Study of DWP-450 for treatment of moderate-to-severe glabellar lines. Evolus. June 2014-October 2016
  17. Principal Investigator, Post approval study of Radiesse for the Treatments of Hands with Moderate to Very Severe Dorsal Volume Loss. Merz Pharmaceuticals. February 2016- Present
  18. Principal Investigator, Randomized Double-Blinded, Placebo Controlled, Muli-Center Trial to Evaluate the Safety and Efficacy and Duration of Effect of DaxibotulinumtoxinA for Injections to Treat Moderate to Severe Glabellar Lines. Revance. 2017-2018
  19. Principal Investigator, An Open-Label Multi-Center to Assess the Safety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection for Treatment of Moderate to Severe Glabellar Lines. Revance. 2017-2018
  20. Principal Investigator, A Multicenter, Open-Label, Prospective Study of Cannula Injection of Restylane Lyft with Lidocaine for Cheek Augmentation and the Correction of Age Related Midface Contour Deficiencies. Galderma. 2017
  21. Principal Investigator, A Multicenter, Single-Blind, Randomized, Controlled Study of the Safety and Effectiveness of JUVEDERM VOLUMA XC Injectable Gel for Cheek Augmentation using Cannula. Allergan 2018
  22. Investigator, Pre-market study of the clinical utility and applications of computerized, digital microscopy in the detection of malignant melanoma. Rodenstock, Inc. 2000-2001
  23. Principal Investigator, Abgenix and Quintiles: Protocol ABX-0204: Part II. A two part, multi-center, randomized, double-blind, placebo controlled, multiple dose clinical trial of ABX-IL8 (a monoclonal antibody IL-8 inhibitor) in patients with moderate to severe plaque psoriasis. 2001-2002
  24. Principal Investigator, A Multi-Center, Double-Blind Placebo Controlled, Parallel Group Study Comparing Bioequivalence 2 Formulations of Metronidazole Gel 0.075% for Rosacea. TEVA Pharmaceuticals. 2001-2002
  25. Investigator, FDA study investigator for SilSkin (highly purified 1000 cs silicone oil) in treating nasolabial folds, mid-malar depressions, oral commissures, and HIV associated facial lipoatrophy. RJ Development, Peabody, MA. 2001

PRESENTATIONS and POSTERS (302# March , 27, 2018E)

  1. Jones D. Poster Presentation. Efficacy of incobotulinumtoxinA for the treatment of glabellar frown lines in male subjects: post-hoc analyses from randomized, double-blind pivotal studies. Presented at the American Academy of Dermatology Annual Meeting. San Diego, CA. February 16, 2018.
  2. Jones D. Understanding the Action of Hyaluronidase in the Relief of HA Filler Arterial Obstruction: Shades of Grey's Anatomy. Presented at the American Society of Dermatologic Surgery Annual Meeting. Chicago, IL. October 7, 2017
  3. Jones D, Kerscher M, Geister T, et al. Efficacy of Xeomin for the Treatment of Glabellar Frown Lines in Male Subjects: Post-Hoc Analyses from Randomized, Double-Blind Pivotal Studies. Presented at the American Society of Dermatologic Surgery Annual Meeting. Chicago, IL. October 6, 2017.
  4. Fabi S, McDiarmid J, Benito-Ruiz J, Bass L, Jones D, et al. Skin Laxity Is Unchanged Among ATX-101 Treatment Responders: Post-Hoc Analysis of Phase 3 Data. Presented at the American Society of Dermatologic Surgery Annual Meeting. Chicago, IL. October 6, 2017
  5. Jones D. Fillers for Scars: Smooth Moves: Advancements in Acne Scaring. Presented at the American Society of Dermatologic Surgery Annual Meeting. Chicago, IL. October 5, 2017.
  6. Jones D. Injectables vs. Threads, When and Why?: ASDS Unplugged. Presented at the American Society of Dermatologic Surgery Annual Meeting. Chicago, IL. October 4, 2017.
  7. Jones D. Co-Director. Hands-on: Dermal Fillers. Presented at the American Academy of Dermatology Annual Meeting. Orlando, FL. March 6, 2017.
  8. Jones D. Dermatologic Surgery: Cosmetic Tips and Pearls. Presented at the American Academy of Dermatology Annual Meeting. Orlando, FL. March 6, 2017.
  9. Jones D. "How to Look Natural" Advanced Botulinum Toxin: Video and Live Panel Discussion. Presented at the American Academy of Dermatology Annual Meeting. Orlando, FL. March 3, 2017.
  10. Jones D. Poster Presentation. A Report of 113 Patients with 10-Year and Beyond Follow-up After Treatment with Highly Purified Liquid Injectable Silicone for HIV Associated Facial Lipoatrophy. Presented at the American Society of Dermatologic Surgery Annual Meeting. New Orleans, LA. November 10, 2016.
  11. Jones D. Poster Presentation. In-Vivo Degradation of Hyaluronic Acid (HA)-Based Fillers by Exogenous Hyaluronidases. Presented at the American Society of Dermatologic Surgery Annual Meeting. New Orleans, LA. November 10, 2016. (First Place Poster Winner)
  12. Jones D. Moderator. Acne Scaring: Managing Patient Expectations and Achieving Optimal Outcomes. Presented at the American Society of Dermatologic Surgery Annual Meeting. New Orleans, LA. November 10, 2016.
  13. Jones D. Co-Director. Hands-on: Dermal Fillers. Presented at the American Academy of Dermatology Annual Meeting. Washington D.C. March 6, 2016.
  14. Jones D. "California Dreaming" Advanced Botulinum Toxin: Video and Live Panel Discussion. Presented at the American Academy of Dermatology Annual Meeting. Washington D.C. March 6, 2016.
  15. Jones D. Dermatologic Surgery: Cosmetic Tips and Pearls. Presented at the American Academy of Dermatology Annual Meeting. Washington D.C. March 5, 2016.
  16. Jones D. Live Demonstration. Soft Tissue Augmentation and Neuromadulators- Simultaneous Cadaver Prosection and Live Patient Injection. Presented at the American Academy of Dermatology Annual Meeting. Washington D.C. March 5, 2016.
  17. Jones D. Facial Sculpting and Fillers: Hot Topics. Presented at the American Academy of Dermatology Annual Meeting. Washington D.C. March 4, 2016.
  18. Jones D. Live Demonstration. Midface Volume Replacement and Volumizing the Cheeks: The State of the Art of Aesthetic Dermatology. Presented at the American Academy of Dermatology Annual Meeting. Washington D.C. March 4, 2016.
  19. Jones D. Director. Finessing the Forehead: Basic Botulinum Toxin: Video and Live Panel Discussion. Presented at the American Academy of Dermatology Annual Meeting. Washington D.C. March 4, 2016.
  20. Jones D. Avoiding and Treating Vascular Accidents with Injectables. Presented at UCLA Grand Rounds. Los Angeles, CA. October 29, 2015.
  21. Jones D. Avoiding and Treating Vascular Accidents When Using Fillers: Advanced Fillers Beyond the Nasolabial Fold. Presented at the American Society of Dermatologic Surgery Annual Meeting. Chicago, IL. October 17, 2015.
  22. Jones D. Injection Techniques and Anatomy: Midface Rejuvenation. Presented at the American Society of Dermatologic Surgery Annual Meeting. Chicago, IL. October 16, 2015.
  23. Jones D. The Latest on Kybella: ASDS Unplugged. Presented at the American Society of Dermatologic Surgery Annual Meeting. Chicago, IL. October 14, 2015.
  24. Jones D. Voluma Compared to other HA Fillers: Facial Rejuvenation. Presented at the World Congress of Dermatology Annual Meeting. Vancouver, B.C. June 13, 2015.
  25. Jones D. Managing Complications of Injectable Fillers: Advanced Dermatologic Surgery. Presented At the World Congress of Dermatology Annual Meeting. Vancouver, B.C. June 12, 2015.
  26. Jones D. Complications: Preventing them and treating them: Fillers and Toxins II. Presented at the World Congress of Dermatology Annual Meeting. Vancouver, B.C. June 12, 2015.
  27. Jones D. Reducing Submental Fat with ATX-101: ASDS State of the Art in Minimally Invasive Aesthetics: Global Advances. Presented at the World Congress of Dermatology Annual Meeting. Vancouver, B.C. June 8, 2015.
  28. Jones D. Mastering the Medial Cheek and Lid-Cheek Junction: ASDS State of the Art in Minimally Invasive Aesthetics: Global Advances. Presented at the World Congress of Dermatology Annual Meeting. Vancouver, B.C. June 8, 2015.
  29. Jones D. Chairperson. American Society of Dermatologic Surgery, State of the Art in Minimally Invasive Aesthetics: Global Advances. Presented at the World Congress of Dermatology Annual Meeting. Vancouver, B.C. June 8, 2015.
  30. Jones D. Director. Cosmetic Tips and Pearls: Avoiding Vascular Accidents in the Temple, Avoiding Vascular Accidents in the Mid Face, Avoiding Vascular Accidents in the Glabella. Presented at the American Academy of Dermatology Annual Meeting. San Francisco, CA March 23, 2015.
  31. Jones D. Director. Hyaluronidase: An Overview of Undoing and the Overdone: Achieving Natural Looking Results with Cosmetic Treatments. Presented at the American Academy of Dermatology Annual Meeting. San Francisco, CA March 23, 2015.
  32. Jones D. Finessing the Forehead: Basic Botulinum Toxin. Presented at the American Academy of Dermatology Annual Meeting. San Francisco, CA. March 22, 2015.
  33. Jones D. Director. Basic Botulinum Toxin. Presented at the American Academy of Dermatology Annual Meeting. San Francisco, CA. March 22, 2015.
  34. Jones D. Director. Anatomy: Hands-On: Dermal Fillers. Presented at the American Academy of Dermatology Annual Meeting. San Francisco, CA. March 21, 2015.
  35. Jones D. Director. Live Demonstration: Expert Injections with Onabotulinum Toxin: Advanced Botulinum Toxin. Presented at the American Academy of Dermatology Annual Meeting. San Francisco, CA. March 21, 2015.
  36. Jones D. Poster Presentation. Efficacy and Safety of Incobotulinumboxin A in the Combined Treatment of Upper Facial Lines: Results of the First Prospective, Randomised, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study. Presented at the American Academy of Dermatology Annual Meeting. San Francisco, CA. March 21, 2015.
  37. Jones D. Chair. Live Demonstration: Temple Revolumization: Soft Tissue Augmentation and Neuromodulators. Presented at the American Academy of Dermatology Annual Meeting. San Francisco, CA. March 20, 2015.
  38. Jones D. Recognizing and Treatment of Filler Complications: Advanced Fillers: Beyond the Nasolabial Fold Course. Presented at American Society of Dermatologic Surgery Annual Meeting. San Diego, CA. November 8, 2014.
  39. Jones D. The Bone and Retaining Ligaments: Shades of Gray: Know your Anatomy Course. Presented at American Society of Dermatologic Surgery Annual Meeting. San Diego, CA. November 7, 2014.
  40. Jones D. Moderator. Part 2- Mid Face Rejuvenation: Injectable Techniques and Anatomy. Presented at American Society of Dermatologic Surgery Annual Meeting. San Diego, CA. November 7, 2014.
  41. Jones D. Chair. Achieving Total Facial Rejuvenation. Presented at American Society of Dermatologic Surgery Annual Meeting. San Diego, CA. November 6, 2014.
  42. Jones D. The Evolution of Injectable Fillers: State of the Art 2014. Mount Sinai Grand Rounds. NY, NY. September 20, 2014.
  43. Jones D. Botulinum Toxins: New Indications, New Treatments and Pearls to Reshape the Face and Neck. Presented at the Masters of Aesthetics Symposium. San Diego, CA. August 23, 2014.
  44. Jones D. Faculty. Chair. The Art and Science of the Aesthetic Analysis. Presented at the Understanding the Diversity of HA Fillers: An Innovative Approach to Maximizing Facial Beauty. Chicago, IL. June 28, 2014.
  45. Jones D. Total Face: From Theory to Practice in Clinic. Presented at the Asia Pacific Medical Aesthetics Congress. Beijing, China. June 12, 2014.
  46. Jones D. Total Face: From Theory to Practice in Clinic. Presented at the Asia Pacific Medical Aesthetics Congress. Shanghai, China. June 11, 2014.
  47. Jones D. Patient Journey & Mastering the Art -My Number 1 'Tip/Technique' Presented at the Asia Pacific Medical Aesthetics Congress. Seoul, Korea. June 7, 2014.
  48. Jones D. Total Face: From Theory to Practice in Clinic. Presented at the Asia Pacific Medical Aesthetics Congress. Seoul, Korea. June 7, 2014.
  49. Jones D. Chair. Treatment of the Total Face vs. Individual Sites- Debates and Discussion. Presented at the Asia Pacific Medical Aesthetics Congress. Seoul Korea. June 7, 2014.
  50. Jones D. Midface: Periorbital, Malar and NLF. Presented at the Asia Pacific Medical Aesthetics Congress. Seoul, Korea. June 6, 2014.
  51. Jones D. The Value to the Patient and Physician in Implementing Total Face Treatment. Presented at the Asia Pacific Medical Aesthetics Congress. Seoul, Korea. June 6, 2014.
  52. Jones D. New Options for Mid-Facial Volumizing. Presented at UCLA Grand Rounds. Los Angeles, CA. May 6, 2014.
  53. Jones D. Faculty. The Art and Science of the Aesthetic Analysis. Presented at the Understanding the Diversity of HA Fillers: An Innovative Approach to Maximizing Facial Beauty. NY, NY. April 12, 2014.
  54. Jones D. It's Belotero Time! How Science Translates into Attractiveness. Presented at the Anti-Aging Medicine World Congress Meeting. Monte Carlo, FR. April 4, 2014.
  55. Jones D. Poster Presentation: Efficacy and Safety of ATX-101. Presented at the American Academy of Dermatology Annual Meeting. Denver, CO. March 24, 2014.
  56. Jones D. Differentiating Botulinum Toxin Type A, Preparations: Basic and Clinical Science: Basic Botulinum Toxin Course. Presented at the American Academy of Dermatology Annual Meeting. Denver, CO. March 24, 2014.
  57. Jones D. Director: Finessing the Forehead: Basic Botulinum Toxin Course. Presented at the American Academy of Dermatology Annual Meeting. Denver, CO. March 24, 2014.
  58. Jones D. Avoiding vascular compromise with midface volumizing, avoiding sensory and motor nerve damage with midface volumizing, avoiding parotid damage with midface volumizing: Dermatologic Surgery Cosmetic Tips and Pearls Course. Presented at the American Academy of Dermatology Annual Meeting. Denver, CO. March 23, 2014.
  59. Jones D. Peri-Orbital: Pears, Pitfalls, Product Preferences: Avoiding and Managing Filler Complications Course. Presented at the American Academy of Dermatology Annual Meeting. Denver, CO. March 22, 2014.
  60. Jones D. Expert Injections with Onabotulinum Toxin: Advanced Botulinum Toxin Course. Presented at the American Academy of Dermatology Annual Meeting. Denver, CO. March 22, 2014.
  61. Jones D. Poster Presentation: Efficacy of Neotensil. Presented at the American Academy of Dermatology Annual Meeting. Denver, CO. March 21, 2014.
  62. Jones D. Live Demonstration: The Challenging Neck. Soft Tissue Augmentation and Neuromodulators- Simultaneous Cadaver Prosection and Live Patient Injections. Presented at the American Academy of Dermatology Annual Meeting. Denver, CO. March 21, 2014.
  63. Jones D. Clinical Trials in Aesthetic Dermatology. Presented at UCLA Grand Rounds. Los Angeles, CA March 6, 2014
  64. Jones D. Faculty. Fillers and Toxins. Presented at Maui Derm. Maui HI. January 27, 2014
  65. Jones D. Hands-on Aesthetic Training: Fillers, Neurotoxins, Combination Treatments and Avoiding Complications. Presented at Orlando Dermatology Aesthetic and Clinical (ODAC). Orlando, FL. January 20, 2014.
  66. Jones D. KOL Panel: What is the Future Landscape of Dermatology. Presented at Orlando Dermatology Aesthetic and Clinical (ODAC). Orlando, FL. January 18, 2014.
  67. Jones D. Live Demonstration. Cutting Edge Strategies in Injectable Procedures. Juvederm Voluma / Radiesse Filler (Cheeks, Cheekbone and Chin) Presented at Orlando Dermatology Aesthetic and Clinical (ODAC). Orlando, FL. January 17, 2014.
  68. Jones D. Moderator. Globalization to Injection Excellence: 3 Experts, 3 Ways. Presented at MAEXS Expert Summit. Paris, France. November 17, 2013.
  69. Jones D. Live Injector. From Injector to Artist: The Upper Face. Presented at MAEXS Expert Summit. Paris, France. November 16, 2013.
  70. Jones D. Moderator. Economic Reality: Getting the Best out of a Single Syringe. Presented at MAEXS Expert Summit. Paris, France. November 16, 2013.
  71. Jones D. Update and New Indications for Botulinum Toxins, Workshop on Soft Tissue Fillers and Botulinum Toxins. Harvard Medical School. Boston, MA. November 9, 2013.
  72. Jones D. Advanced Techniques: The Non-Surgical Lift. Presented at American Society for Dermatologic Surgery, The Art and Science of Soft-Tissue Fillers and Neuromodulators. NY, NY. October 27, 2013.
  73. Jones D. What's on the Horizon for Dermal Fillers and Botulinum Toxins? Presented at American Society for Dermatologic Surgery, The Art and Science of Soft-Tissue Fillers and Neuromodulators. NY, NY. October 27, 2013.
  74. Jones D. My Technique for Treating the Neck. Presented at American Society for Dermatologic Surgery, The Art and Science of Soft-Tissue Fillers and Neuromodulators. NY, NY. October 26, 2013.
  75. Jones D. My Technique for Midface Volumizing and the Nasolabial Fold. Presented at American Society for Dermatologic Surgery, The Art and Science of Soft-Tissue Fillers and Neuromodulators. NY, NY. October 26, 2013.
  76. Jones D. My Technique for Treating the Forehead and Glabellar Regions. Presented at American Society for Dermatologic Surgery, The Art and Science of Soft-Tissue Fillers and Neuromodulators. NY, NY. October 26, 2013.
  77. Jones D. Marketing Procedures to Your Patients. Presented at American Society for Dermatologic Surgery, The Art and Science of Soft-Tissue Fillers and Neuromodulators. NY, NY. October 26, 2013.
  78. Jones D. Long Standing Fillers and Implants: Silicone, Volumizing HA and Permanent Implants. Presented at American Society for Dermatologic Surgery, The Art and Science of Soft-Tissue Fillers and Neuromodulators. NY, NY. October 26, 2013.
  79. Jones D. Evolution of Injectable Fillers: State of the Art 2013. NYU Grand Rounds. NY, NY. October 25, 2013.
  80. Jones D. Faculty. Live Demonstration, Innovations in Facial Aesthetic Medicine. Satellite Symposium at ASPS, Pasadena, CA. October 23, 2013.
  81. Jones D. New Indications for Botulinum Toxin. American Academy of Facial Plastic Surgery and Reconstruction Annual Meeting. San Diego, CA. October 19, 2013.
  82. Jones D. Cheek Augmentation with Voluma: Results from the FDA Pivotal Trial. American Academy of Facial Plastic Surgery and Reconstruction Annual Meeting. San Diego, CA. October 19, 2013.
  83. Jones D. Faculty, Innovations in Facial Aesthetic Medicine. Satellite Symposium at ASPS Annual Meeting, San Diego, CA. October 13, 2013.
  84. Jones D. Cheek Augmentation with Voluma: Results from the FDA Pivotal Trial. Presented in the Hot Topics Session, American Society for Plastic Surgery Annual Meeting. San Diego, CA. October 11, 2013.
  85. Jones D. Heterogeneity of Crow's Feet Line Patterns. Presented in Cosmetic Oral Abstract Session, American Society for Dermatologic Surgery Annual Meeting. Chicago, IL. October 5, 2013.
  86. Jones D. Cheek Augmentation with Voluma: Results from the FDA Pivotal Trial. Presented in Cosmetic Oral Abstract Session, American Society for Dermatologic Surgery Annual Meeting. Chicago, IL. October 5, 2013.
  87. Jones D. Mona Lisa Mastery: Facial Shaping. Presented at the American Society for Dermatologic Surgery Annual Meeting. Chicago, IL. October 5, 2013.
  88. Jones D. Moderator. Controversies in Dermatologic Surgery. Presented at the American Society for Dermatologic Surgery Annual Meeting. Chicago, IL. October 4, 2013.
  89. Jones D. Mid Face. Fillers and Toxins: Video Demonstrations. Vegas Cosmetic Surgery & Aesthetic Dermatology. Las Vegas, NV. June 27, 2013.
  90. Jones D. Faculty, Innovations in Facial Aesthetic Medicine. Satellite Symposium at ASAPS. NY, NY. April 12, 2013.
  91. Glaser A, Jones D, Carruthers J, Largent J, Caulkins C. Abstract: Epidemiologic Analysis of Eyelash Characteristics With Increasing Age in a Population of Healthy Women. Presented at the American Academy of Dermatology Annual Meeting. Miami, FL. March 4, 2013.
  92. Jones D. Faculty. Finessing the Fickle and Formidable Frontalis and Basic Botulinum Toxin. The American Academy of Dermatology Annual Meeting. Miami, FL. March 4, 2013.
  93. Jones D. Faculty. Dermatologic Surgery: Cosmetic Tips and Pearls. Presented at the American Academy of Dermatology Annual Meeting. Miami, FL. March 2, 2013.
  94. Jones D. Faculty. Live Demonstration, Application of Our Aesthetic Toolbox for the Treatment of Medical and Dermatologic Disorders. Presented at the American Academy of Dermatology Annual Meeting. Miami, FL. March 2, 2013.
  95. Jones D. Faculty. Live Demonstration, The State of The Art of Aesthetic Dermatology. Presented at the American Academy of Dermatology Annual Meeting. Miami, FL. March 2, 2013.
  96. Jones D. Faculty. Live Demonstration, Advanced Botulinum Toxin. Presented at the American Academy of Dermatology Annual Meeting. Miami, FL. March 1, 2013.
  97. Jones D. Abstract: Crow's Feet 099 Poster, Efficacy and Safety of OnabotulinumtoxinA for the Treatment of Crow's Feet Lines Alone or in Combination with Glabellar Lines: A Multicenter Randomized Controlled Tria. Maui Derm. Maui, HI. January 19, 2013.
  98. Jones D. Faculty. Live Injection Fillers. Maui Derm. Maui, HI. January 19, 2013.
  99. Jones D. Mid-Face Volumizing. Presented at the American Society for Dermatologic Surgery Annual Meeting course "The Art and Science of Soft-Tissue Fillers and Neuromodulators." San Diego, CA. November 11, 2012.
  100. Jones D. The Technique for the Perfect Lip. Presented at the American Society for Dermatologic Surgery Annual Meeting course "The Art and Science of Soft-Tissue Fillers and Neuromodulators." San Diego, CA. November 10, 2012.
  101. Jones D. The Hyaluronic Family and Calcium Hydroxylapatite. Presented at the American Society for Dermatologic Surgery Annual Meeting course "The Art and Science of Soft-Tissue Fillers and Neuromodulators." San Diego, CA. November 10, 2012.
  102. Jones D. Faculty. Botulinum Toxin Workshop. Presented at The 2012 Fall Clinical Dermatology Conference. Las Vegas, NV. October 6, 2012.
  103. Jones D. New Applications for Botulinum Toxin. Presented at The 2012 Fall Clinical Dermatology Conference. Las Vegas, NV. October 5, 2012.
  104. Jones D. Cutaneous Surgery and Aesthetics Symposium: New Options for Facial Volumizing. Presented at the Pacific Dermatological Association's Annual Meeting. Huntington Beach, CA. August 25, 2012.
  105. Jones D. Activity: My Clinical Experience with Latisse. Presented at the Allergan Latin America Scientific Conference. Miami, FL. August 25, 2012.
  106. Jones D. Facial Anatomy and Advanced Injection Technique: The Use of Hyaluronidase to Manage Complications. Presented at the Allergan Latin America Scientific Conference. Miami, FL. August 24, 2012.
  107. Jones D. Facial Anatomy and Advanced Injection Technique: Cheekbones and Midface Volumizing in Different Patient Profiles- Square and Round Face. Presented at the Allergan Latin America Scientific Conference. Miami, FL. August 24, 2012.
  108. Jones D. Facial Anatomy and Advanced Injection Technique: Eyebrow Shape and Temples. Presented at the Allergan Latin America Scientific Conference. Miami, FL. August 24, 2012.
  109. Jones D. Planning and Patient Assessment: Patient Assessment and Planning. Presented at the Allergan Latin America Scientific Conference. Miami, FL. August 24, 2012.
  110. Jones D. Faculty, Live Injection Session #3. CBC, Colorado Springs, CO. July 20, 2012
  111. Jones D. Fillers and Beyond: Mid-Face Volumizing. CBC, Colorado Springs, CO. July 20, 2012
  112. Jones D. Moderator, Live Injection Session #2. CBC, Colorado Springs, CO. July 20, 2012.
  113. Jones D. Mid-Face Volumizing. Presented at UCLA Grand Rounds. Los Angeles, CA April 4, 2012
  114. Jones D. 'Finessing the Frontailis' Presented on Forehead Injection. American Academy of Dermatology Annual Meeting. San Diego, CA. March 20, 2012
  115. Jones D. Basic Botulinum Toxin. Presented at the American Academy of Dermatology Annual Meeting. San Diego, CA. March 20, 2012
  116. Jones D. 10 Years' Experience with Treatment for HIV Associated Lipoatrophy with Silicone 1000. Presented at the American Academy of Dermatology Annual Meeting. San Diego, CA. March 18, 2012
  117. Jones D. Faculty. Live Demonstration, Volumizing the Mid-Face, Presented on The State of the Art of Aesthetic Dermatology Course. American Academy of Dermatology. San Diego, CA March 17, 2012
  118. Jones D. Faculty. Live Demonstration, Disorders of the Periorbital Region, Presented in Application of Our Aesthetic Toolbox for the Treatment of Medical and Dermatologic Disorders Course. American Academy of Dermatology. San Diego, CA March 17, 2012
  119. Jones D. Faculty. Live Demonstration with Incobotulinum, Presented on Advanced Botulinum Toxin Course. American Academy of Dermatology. San Diego, CA March 16, 2012
  120. Jones D. Options for Mid-Face Volumizing. Presented at Harbor-UCLA Grand Rounds. Torrance, CA. March 15, 2012
  121. Jones D. Faculty. Dermal Fillers Lecture, Maui Derm. Maui, HI February 7, 2012.
  122. Jones D. Faculty. Live Demonstration, Maui Derm. Maui, HI February 7, 2012.
  123. Jones D. Faculty. Faceforward; Advanced Non-Surgical Aesthetic Medicine, Presented by Spire Learning. Los Angeles, CA January 21, 2012.
  124. Jones D. Facial Shaping. Presented at the American Society for Dermatologic Surgery Annual Meeting. Washington D.C. November 5, 2011.
  125. Jones D. Physician Extenders in Dermatology. Presented in Controversies in Dermatologic Surgery. American Society for Dermatologic Surgery Annual Meeting. Washington D.C. November 4, 2011.
  126. Jones D. Advanced Fillers: First This, Then Demo's. Presented at the American Society for Dermatologic Surgery Annual Meeting. Washington D.C. November 3, 2011.
  127. Jones D. Stress Reduction and Physician Wellness. Presented at the American Society for Dermatologic Surgery Annual Meeting course "Practice Management in the Era of Health Care Reform." Washington D.C. November 2, 2011.
  128. Jones D. What is the Future of Dermatologic Surgery? Presented at the ASDS course "Practice Management in the Era of Health Care Reform." Washington D.C. November 2, 2011.
  129. Jones D. Faculty, Live Injection Session. CBC, Aspen, CO. July 15, 2011.
  130. Jones D. Beyond Spackle: Combination Treatment of the Lower Face. CBC, Aspen, CO. July 15, 2011
  131. Jones D. Faculty, Human Cadaver Facial Dissection Workshop; designed to improve the safety of aesthetic injectables. www.cmecommunity.com. July, 2011
  132. Jones D. Annual London FACE (Facial Aesthetics Conference and Exhibition). Chair of multiple sessions and workshop "Male Facial Contouring using Fillers and Toxins". June 24-26, 2011
  133. Jones D. Complications of Fillers. Presentation at Summit in Aesthetic Medicine, Dana Point California. June 11, 2011
  134. Jones D. Complications of Toxins. Presentation at Summit in Aesthetic Medicine, Dana Point California. June 11, 2011
  135. Jones D. Hyaluronic Acids: Are They the Only Fillers You Need? Presentation at Summit in Aesthetic Medicine, Dana Point California. June 10, 2011
  136. Jones D. Options for Mid Face Volumizing. Presented in "Aesthetic Dermatology for the Experienced Session" at the 22nd World Congress of Dermatology. Seoul Korea, May 27, 2011.
  137. Jones D. Update on Hyaluronic Acid Filling Agents. Presented at the American Academy of Dermatology Annual Meeting, New Orleans, LA. February 7, 2011
  138. Jones D. Botulinum Toxins for Peri-Orbital Area. Presented at the American Academy of Dermatology Annual Meeting, New Orleans, LA. February 7, 2011.
  139. Jones D. Treating the Upper Third of the Face with Botox while Maximizing Brow Elevation. Advanced Botulinum Toxin. Presented at the American Academy of Dermatology Annual Meeting, New Orleans, LA. February 5, 2011.
  140. Jones MD. Scientific Chair. The Merz Portfolio: Radiesse and Bocouture". IMCAS Annual Meeting. Paris France. January 8, 2010.
  141. Jones D. How would you treat this patient? Measures of Age-Related Change. Presented at the ASDS course "Art and Science of Fillers and Injectables." San Francisco, CA. November 21, 2010.
  142. Jones D. My technique for Treating Nasolabial and Periorbital Areas. Presented at the ASDS course "Art and Science of Fillers and Injectables." San Francisco, CA. November 20, 2010.
  143. Jones, D. Botulinum Toxins Overview. Presented at the ASDS course "Art and Science of Fillers and Injectables." San Francisco, CA. November 20, 2010.
  144. Jones D, Rotunda A. Poster Presentation: HIV-Associated Lipohypertrophy (Buccal Fat Lipoma-Like Lesions) Reduced with Subcutaneously Injected Sodium Deoxycholate. American Society for Dermatologic Surgery Annual Meeting, Chicago, IL October 24, 2010.
  145. Jones D. Poster Presentation: The Use of Hyaluronic Acid in the Treatment of Moderate to Severe Nasolabial Folds: An Analysis of Treatment Longevity in an Open-Label Extension (OLEX) Study. American Society for Dermatologic Surgery Annual Meeting, Chicago, IL October 24, 2010.
  146. Jones D. Poster Presentation: Hyaluronic Acid is Superior to Collagen in the Correction of Moderate to Severe Nasolabial Folds: Results From a Randomized Blinded, Controlled, Multicenter Trial. American Society for Dermatologic Surgery Annual Meeting, Chicago, IL October 24, 2010.
  147. Jones D. A Report of 135 Patients with 5 Year and Beyond Follow Up After Treatment with Highly Purified Liquid Injectable Silicone (LIS) for HIV Associated Facial Lipoatrophy (HIV FLA). American Society for Dermatologic Surgery Annual Meeting, Chicago, IL October 24, 2010.
  148. Jones D. Alginate: European Experience. In Fillers Part II. American Society for Dermatologic Surgery Annual Meeting, Chicago, IL October 23, 2010.
  149. Jones D. Liquid Injectable Silicone and Novel Permanent Fillers. In Fillers Part II. American Society for Dermatologic Surgery Annual Meeting, Chicago, IL October 23, 2010.
  150. Jones D. Moderator: Fillers Part II. American Society for Dermatologic Surgery Annual Meeting, Chicago, IL October 23, 2010.
  151. Jones D. Moderator: Fillers Part I. American Society for Dermatologic Surgery Annual Meeting, Chicago, IL October 23, 2010.
  152. Jones D. Tea with the Masters: Silicone Injections. American Society for Dermatologic Surgery Annual Meeting, Chicago, IL October 22, 2010.
  153. Jones, D. Presentation "Hyaluronic Acids" and Faculty for full afternoon of live injection teaching session for Residents. . Presented at Cosmetic Boot Camp University, Marina Del Ray, CA. October 30, 2010.
  154. Jones D. Hyaluronic Acid Fillers: Beyond Nasolabial Folds. Presented at the Pacific Dermatological Association's Annual Meeting, Pasadena, CA. August 14, 2010.
  155. Jones D. Injectable Fillers, What's New? Presented at the annual FACE meeting, London, July 3rd, 2010.
  156. Jones D. What's New in Injectable Fillers? Presented at UCLA Department of Dermatology Grand Rounds. June 8, 2010.
  157. Jones D. Skin Cancer Presentation for Neutrogena's Skin Health, in conjunction with ASDS, at the Neutrogena Corporation, Los Angeles, CA, May 18th, 2010.
  158. Jones D. Periocular Botox. Presented in the Basic Botulinum Course, AAD Annual Meeting in Miami, FL, March 6, 2010.
  159. Jones D. Hyaluronans: Basic Science. Presented at Maui Derm, January 27, 2010
  160. Jones D. Novabel Unplugged. Presented at IMCAS Annual Meeting, Paris, France. January 9, 2010.
  161. Jones D. Hyaluronans and Collagen. Presented at Cosmetic Bootcamp University, San Francisco. November 7, 2009.
  162. Jones D. Enhancement vs. Rejuvenation. Keynote address, Canadian FACE Annual meeting. October 18, 2009.
  163. Jones D, In-Vitro Resistance to Degradation of HA by Ovine Testicular Hyaluronidase. Late Breaking Abstract Presentation, American Society for Dermatologic Surgery Annual Meeting, Phoenix, Arizona. October 4, 2009.
  164. Jones, D. "Combination Therapy: Fillers, Volumizers and Botulinum Toxin". In Advanced Botulinum Toxin Course. American Academy of Dermatology Annual Meeting, San Francisco, CA. March 9, 2009.
  165. Jones, D. "The New Fillers: Better, Safer, or is there Trouble Ahead?" In Hot-Topics Symposium. American Academy of Dermatology Annual Meeting, San Francisco, CA. March 7, 2009.
  166. Jones, D. "Silicone and Poly-lactic Acid: Emerging Concepts". In Soft Tissue Augmentation Course. American Academy of Dermatology Annual Meeting, San Francisco, CA. March 7, 2009.
  167. Jones D. Course Moderator. Soft Tissue Augmentation Course. American Academy of Dermatology Annual Meeting, San Francisco, CA. March 7, 2009.
  168. Jones, D. "Botulinum Toxin for the Peri-orbital area with Video". In Basic Botulinum Toxin Course. American Academy of Dermatology Annual Meeting, San Francisco, CA. March 6, 2009.
  169. Jones, D. Faculty: General Injections Toxins and Fillers; Sessions 1 and 2 and Small Group Training Sessions. At Maui Derm 209, Maui, HI, January 30, 2009.
  170. Jones, D. "Combination Fillers and Toxins: The role of facial shaping agents in the context of Non-Surgical Total Facial Rejuvenation. How and why combinations work synergistically." At Maui Derm 2009, Maui, HI, January 30, 2009
  171. Jones D. "Combination Fillers and Toxins: Product category review, mechanism of action and characteristics of dermal fillers available in the US." At Maui Derm. 2009, Maui, HI, January 30, 2009.
  172. Jones D. New Validated Aesthetic Rating Scales. In "Latest Research in Fillers and Injectables." American Society of Dermatologic Surgery 2008 Annual Meeting, Orlando, FL, November 9, 2008.
  173. Jones D. "Will We Ever Find a Better, More Universal Filler than the Cross Linked Hyaluronic Acid?" In Dermatologic Surgery Controversies. American Society of Dermatologic Surgery 2008 Annual Meeting, Orlando, FL, November 8, 2008.
  174. Jones D. "Facial Volumizing Techniques". American Society of Dermatologic Surgery "The Art and Science of Fillers and Injectables". Los Angeles, CA. October 4-5, 2008.
  175. Jones D. Botulinum Toxins Overview. American Society of Dermatologic Surgery "The Art and Science of Fillers and Injectables". Los Angeles, CA. October 4-5, 2008.
  176. Jones D. Director and Moderator, American Society of Dermatologic Surgery "The Art and Science of Fillers and Injectables". Los Angeles, CA. October 4-5, 2008.
  177. Jones D. Faculty for " Fillers and Botulinum Toxins: Advanced Techniques" supported by StrataMed and Allergan. September 13, 2008, Boston, MA.
  178. Jones D. Faculty for " Fillers and Botulinum Toxins: Advanced Techniques" supported by StrataMed and Allergan. Las Vegas, NV, August 23, 2008.
  179. Jones D. "Semi-Permanent and Permanent Fillers". Presented at the 60th Annual Pacific Dermatological Meeting, San Francisco, CA. August 7, 2008.
  180. Jones D. "Botox and Fillers in Beverly Hills: The Celebrity Look". Presented at the annual International Facial Aesthetics Conference and Exhibition, London, England. June 29, 2008.
  181. Jones D. "Facial Volumizing and Botox in Men". Presented at the annual International Facial Aesthetics Conference and Exhibition, London, England. June 28, 2008.
  182. Jones D. Faculty for " Fillers and Botulinum Toxins: Advanced Techniques" supported by StrataMed and Allergan. Atlanta, GA, June 21, 2008.
  183. Jones D. Faculty, National Juvederm Speaker Training Seminar. Las Vegas, NV. May 16th-18th, 2008.
  184. Jones D. Chairman, Managing Atypical and Unusual Cases. Presented in Allergan's "The Science of Rejuvenation" National Exchange Forum, San Diego, CA, March 28-30, 2008.
  185. Jones D. "Contouring and Volumizing with Sculptra and LIS", Skin Disease Education Foundation 32nd Annual Hawaii Dermatology Seminar, Kona, Hawaii, March 7th, 2008.
  186. Jones D. Botulinum Toxin Type A- Finessing the Forehead and Brow, Skin Disease Education Foundation 32nd Annual Hawaii Dermatology Seminar, Kona, Hawaii, March 7th, 2008.
  187. Jones D. Course Director: Advances in Cosmetic Dermatology, Skin Disease Education Foundation 32nd Annual Hawaii Dermatology Seminar, Kona, Hawaii, March 7th, 2008.
  188. Jones D. Achieving Consistent Long-Term Outcomes with HA Fillers, Skin Disease Education Foundation 32nd Annual Hawaii Dermatology Seminar, Kona, Hawaii, March 7th, 2008.
  189. Jones D. Faculty, Visual Learning Session -Understanding New Aesthetic Techniques through observation, Skin Disease Education Foundation 32nd Annual Hawaii Dermatology Seminar, Kona, Hawaii, March 3rd, 2008.
  190. Jones D. Sculptra and Silicone: overview and injection techniques. In Soft Tissue Augmentation Course, American Academy of Dermatology 66th Annual Meeting, San Antonio, TX, February 4th 2008.
  191. Jones D. Director: Forum Director, Fillers, American Academy of Dermatology 66th Annual Meeting, San Antonio, TX, February 3rd 2008.
  192. Jones D. Silicone for facial atrophy, in Silicone Forum, American Academy of Dermatology 66th Annual Meeting San Antonio, TX, February 2nd 2008.
  193. Jones D. Liquid Silicone for Facial Atrophy, 10th Annual Meeting, International Master Course on Aging Skin, Paris, France, January 11th, 2008.
  194. Jones D. Co-Chair: Live and Video Demos for what's new lectures: Fillers, Peelings and Mesotherapy, 10th Annual Meeting, International Master Course on Aging Skin, Paris, France, January 11th, 2008.
  195. Jones D. Chair: Fundamentals: New Developments in Imagery, 10th Annual Meeting, International Master Course on Aging Skin, Paris, France, January 10th, 2008.
  196. Jones D. Shaping the Face of Aesthetic Medicine: Advanced Techniques. Faculty for training seminar sponsored by Allergan. Los Angeles, CA, December 15, 2007.
  197. Jones D. Shaping the Face of Aesthetic Medicine: Advanced Techniques. Faculty for training seminar sponsored by Allergan. New York, NY, December 1, 2007.
  198. Jones D. "Managing the Dissatisfied Patient", in All about Botulinum Toxins. American Society of Dermatologic Surgery Annual Meeting 2007; Chicago, IL, October 12, 2007.
  199. Jones D. Course Co-Director: Advances in Silicone. American Society of Dermatologic Surgery Annual Meeting 2007; Chicago, IL, October 12, 2008.
  200. Jones D. "Super technician vs. the hybrid physician: Does overspecialization blunt the mind?" in Dermatologic and Laser Controversies, American Society of Dermatologic Surgery Annual Meeting 2007; Chicago, IL, October 12, 2007.
  201. Jones D. Shaping the Face of Aesthetic Medicine: Advanced Techniques. Faculty for training seminar sponsored by Allergan. Garden Grove, CA, August 29, 2007.
  202. Jones D. Reconstructive options for facial lipoatrophy. Presented at the Consensus Summit on HIV Metabolic and Morphologic Abnormalities. Boston, MA, August 18, 2007.
  203. Jones D. Past, Present and Future of Fillers. Grand Rounds Basic and Clinical Sciences Lecture Series, UCLA Division of Dermatology, Los Angeles, CA, August 21, 2007.
  204. Jones D. Shaping the Face of Aesthetic Medicine: Advanced Techniques. Faculty for training seminar sponsored by Allergan, Santa Clara, CA, June 24, 2007.
  205. Jones D. Shaping the Face of Aesthetic Medicine: Advanced Techniques. Faculty for training seminar sponsored by Allergan, New Orleans, LA, June 16, 2007.
  206. Jones D. Botox in Male Patients. IMCAS Master Seminars, Paris France, June 1, 2007.
  207. Jones D. Liquid Injectable Silicone vs. Calcium Hydrolxyapetite. IMCAS Master Seminars, Paris France, June 1, 2007.
  208. Jones D. Chairman, "The New Challenge of Facial Contour Rejuvenation". IMCAS Master Seminars, Paris France, June 1, 2007.
  209. Jones D. Silicone. Presented at the Skin Disease Education Foundation's Cosmetic Dermatology Seminar, Orlando, FL., May 4, 2007.
  210. Jones D. Faculty, Visual Learning Session, Skin Disease Education Foundation 31st Annual Hawaii Dermatology Seminar, Maui, Hawaii, March 8, 2007.
  211. Jones D. Full Facial Rejuvenation. Portraits in patient satisfaction. A case-based video presentation. Presented at Skin Disease Education Foundation, 31st Annual Hawaii Dermatology Seminar, Maui, March 8, 2007.
  212. Jones D. Past, Present and Future of Fillers. Presented at Skin Disease Education Foundation, 31st Annual Hawaii Dermatology Seminar, Maui, March 8, 2007.
  213. Jones D. Treatment of HIV lipodystophy. Presented at Skin Disease Education Foundation, 31st Annual Hawaii Dermatology Seminar, Maui, March 5, 2007.
  214. Jones D. Director, State of the Art: Novel Therapeutics at the Intersection of Cosmetic and Medical Dermatology. Skin Disease Education Foundation, 31st Annual Hawaii Dermatology Seminar, Maui, March 5, 2007.
  215. Jones D. Shaping the Face of Aesthetic Medicine. Faculty for training seminar sponsored by Allergan, March 3, 2007, Memphis, TN.
  216. Jones D. Shaping the Face of Aesthetic Medicine. Faculty for training seminar sponsored by Allergan, February 24, 2007, San Antonio, TX.
  217. Jones D. Director, "Fillers" Forum Session. American Academy of Dermatology Annual Meeting, Washington D.C., February 6, 2007.
  218. Jones D. Liquid silicone for facial lipoatrophy. Presented in "Controversies in Silicone" forum, American Academy of Dermatology Annual Meeting, Washington, D.C., February 1, 2007.
  219. Jones D. Liquid Injectable Silicone: Past, present and future. Presented in Filler Symposium, American Academy of Dermatology Annual Meeting, Washington, D.C., February 1, 2007.
  220. Jones D. Shaping the Face of Aesthetic Medicine. Faculty for training seminar sponsored by Allergan, January 27, 2007, Newport Beach, CA.
  221. Stacy Smith, Jones D, et al. Poster presentation: Efficacy and safety following repeat treatment for a new family of hyaluronic acid based fillers. International Masters Course on Aging Skin (IMCAS), January 12, 2007, Paris, France.
  222. Jones D. Facial contouring with liquid injectable silicone vs. calcium hydroxylapetite vs. polylactic acid. International Masters Course on Aging Skin (IMCAS), January 12, 2007, Paris, France.
  223. Jones D. Director, Course on facial contouring with fat, injectables and hard implants. International Masters Course on Aging Skin (IMCAS), January 12, 2007, Paris, France.
  224. Jones D. Deoxycholate injections for HIV lipoaccumulation. International Masters Course on Aging Skin (IMCAS), January 12, 2007, Paris, France.
  225. Jones D. FDA efficacy and safety studies of Juvederm for nasolabial fold corrections. International Masters Course on Aging Skin (IMCAS), January 12, 2007, Paris, France.
  226. Jones D. Long Durability and non-resorbable fillers: What's new in the US? International Masters Course on Aging Skin (IMCAS), January 12, 2007, Paris, France.
  227. Jones D. Botox: Dosing and Aesthetic Considerations in the Male Patient. International Masters Course on Aging Skin, January 11, 2007, Paris, France.
  228. Jones D. Silicone vs. Temporary Fillers. International Masters Course on Aging Skin, January 11, 2007, Paris, France.
  229. Jones D. Shaping the Face of Aesthetic Medicine. Faculty for training seminar sponsored by Allergan, November 4, 2006, Atlanta, GA.
  230. Jones D. Faculty and treating physician for live injection training sessions at American Society for Dermatologic Surgery, October 27 and 28, 2006, Palm Springs, CA.
  231. Jones D. Liquid Injectable Silicone. Forum session at American Society for Dermatologic Surgery Annual Meeting, October 26, 2006, Palm Springs, CA.
  232. Jones D. Faculty and treating physician for live injection demonstration for Allergan's National Education Faculty Training, September 23, 2006, Dana Point, CA.
  233. Jones D. Shaping the Face of Aesthetic Medicine. Faculty for training seminar sponsored by Allergan, September 18, 2006, Beverly Hills, CA.
  234. Jones D. Faculty and treating physician for live injection session for Allergan's national Manager's training, August 29, 2006, Anaheim, CA.
  235. Jones D. Choosing the right filler for each patient. 58th Annual Meeting of the Pacific Dermatological Association, August 13, 2006, Monterey, CA.
  236. Jones D. Shaping the Face of Aesthetic Medicine. Faculty for training seminar sponsored by Allergan, August 11, 2006, Houston, TX.
  237. Jones D. Faculty, ISCLS Master's Series workshop in cosmetic and laser surgery, Aug 3-5, 2006, Los Angeles, CA. (UCLA Div. of Derm. hosted).
  238. Stacy Smith, Jones D, et al. Poster presentation: Efficacy and safety following repeat treatment for a new family of hyaluronic acid based fillers. Presented at the Academy '06 meeting of the American Academy of Dermatology; July 26th-30th, 2006; San Diego, CA
  239. Jones D. Choosing the best filler for each patient, in Cosmetic Dermatology Symposium. American Academy of Dermatology Annual Summer Academy Meeting, July 27th, 2006, San Diego, CA.
  240. Jones D. Shaping the Face of Aesthetic Medicine. Faculty for training seminar sponsored by Allergan, June 8, 2006, Anaheim, CA.
  241. Jones D. Silicone. Skin Disease Education Foundation's Cosmetic Dermatology Seminar, Phoenix Arizona, May 3-7, 2006.
  242. Jones D. Silicone for Facial Lipoatrophy. Presented in Silicone Forum. American Academy of Dermatology Annual Meeting, San Francisco, CA. March 4, 2006.
  243. Jones D. Live injection session, faculty and treating physician. Basic Botulinum Toxin Course. American Academy of Dermatology Annual Meeting, San Francisco, CA. March 4, 2006.
  244. Jones D. HIV Lipoatrophy. Presented in AIDS and STD Session. American Academy of Dermatology Annual Meeting, San Francisco, CA. March 4, 2006.
  245. Jones D. Selecting the Appropriate Filler is Key to Successful Treatment. Media Briefing. American Academy of Dermatology Annual Meeting, San Francisco, CA. March 3, 2006.
  246. Jones D. Combined Fillers for Lip Augmentation. Presented in "Fillers" Forum Session. American Academy of Dermatology Annual Meeting, San Francisco, CA. March 3, 2006.
  247. Jones D. Poly-L-Lactic Acid for Facial Volume Loss. Presented in "Fillers" Forum Session. American Academy of Dermatology Annual Meeting, San Francisco, CA. March 3, 2006.
  248. Jones D. Director, "Fillers" Forum Session. American Academy of Dermatology Annual Meeting, San Francisco, CA. March 3, 2006.
  249. Jones D. Lip Augmentation: Volume vs. Structure. Presented at the Skin Disease Education Foundation 30th Annual Hawaii Dermatology Seminar, Kauai, Hawaii, February 17, 2006.
  250. Jones D. Silicone Injections in 2006. Presented at the Skin Disease Education Foundation 30th Annual Hawaii Dermatology Seminar, Kauai, Hawaii, February 17, 2006.
  251. Jones D. Poly-L-Lactic Acid. Presented in Visual Learning Session, Skin Disease Education Foundation 30th Annual Hawaii Dermatology Seminar, Kauai, Hawaii, February 12, 2006.
  252. Jones D. Poly-L-Lactic Acid for Facial Volume Loss. Presented at the Skin Disease Education Foundation 30th Annual Hawaii Dermatology Seminar, Kauai, Hawaii, February 11, 2006.
  253. Jones D. Advances in Reconstruction of Facial Lipoatrophy. CME seminar supported by an unrestricted grant from Dermik. Westwood, CA, December, 2005.
  254. Jones D. Panelist, Live Surgery Course. Annual Meeting of the American Society for Dermatologic Surgery. Atlanta, Georgia, October 2005.
  255. Jones D. Liquid injectable silicone for lipoatrophy. In Controversies in Silicone Course, Annual Meeting of the American Society for Dermatologic Surgery. Atlanta, Georgia, October 2005.
  256. Jones, D. Basic Dermoscopy. Lecture presented to UCLA Dermatology Residents, UCLA Division of Dermatology, July 5, 2005.
  257. Jones, D. The New World of Fillers. Presented at Grand Rounds, UCLA Division of Dermatology, July 5, 2005.
  258. Jones, D. Silicone. Cosmetic Dermatology Symposium, Skin Disease Education Foundation, Anaheim, CA, May 13, 2005.
  259. Jones D. Botox in Men. Botox Update Forum, 2005 AAD Annual Meeting, New Orleans, LA. February 18, 2005.
  260. Jones D. Fillers to treat large facial areas such as lipoatrophy. Soft Tissue Augmentation Course, 2005 AAD Annual Meeting, New Orleans, LA. February 18, 2005.
  261. Jones D. Focus Session: Treatment Options for Facial Lipoatrophy. Presented at the 2005 AAD Annual Meeting, New Orleans, LA. February 18, 2005
  262. Jones D. Liquid Injectable Silicone for Facial Lipoatrophy. Presented by Being Alive. Los Angeles. February 16, 2005.
  263. Jones D. Combination use of Fillers. Presented at the 2004 "Breakthroughs in Cosmetic Surgery" Symposium, Los Angeles, CA. January 23, 2005.
  264. Jones D. The New World of Fillers. Presented at the 2005 Caribbean Dermatology Symposium, Aruba. January 21, 2005.
  265. Jones D. Treatment of Facial Lipoatrophy. Presented at the "Focus on the Future" Symposium produced by the UCLA AIDS Institute and Cedars-Sinai Medical Center. January 13, 2005.
  266. Jones D. Hyaluronic Acid. Presentation for the American Society of Cosmetic Dermatology and Aesthetic Surgery. Phoenix, AZ. December 3, 2004.
  267. Jones D. Combination Use of Fillers. Presented on behalf of Inamed for the Los Angeles 2004 Cosmetic Expo. November 6, 2004
  268. Jones D. Botox Update. Guest speaker for the Los Angeles Metropolitan Dermatological Society monthly meeting. October 26, 2004.
  269. Jones D. Liquid Injectable Silicone. ASDS Filler Course. San Francisco, CA. August 28, 2004
  270. Jones D. Liquid Injectable Silicone. ASDS Filler Course. Los Angeles, CA August 21,2004.
  271. Jones D. Treatment of Facial Lipoatrophy. Pacific Dermatologic Society Annual Meeting, August 14, 2004, Newport Beach, CA.
  272. Jones D, Bauman L. Breakthroughs in Facial Rejuvenation. Laguna, CA , June 19, 2004. Sponsored by Inamed as training session for Hylaform.
  273. Jones D. Treatment Options for HIV Facial Lipoatrophy. Presented at "New Solutions to Old Problems, Optimal Management of the Sequelae of Long-term HIV Infection and Chronic Antiretroviral Therapy", presented by the UCLA AIDS Institute, June 18, 2004
  274. Jones, D. Highly purified 1000 cs liquid injectable silicone for HIV associated facial lipoatrophy. Changing the Face of HIV. Joint Program of UCSD and Being Alive, San Diego. June 15, 2004.
  275. Jones, D. Silicone study for HIV Facial Lipoatrophy. Cosmetic Dermatology Symposium, Skin Disease Education Foundation, Orlando Florida, May 13, 2004.
  276. Jones D. Focus Session: Treatment Options for HIV Associated Lipoatrophy. American Academy of Dermatology Annual Meeting, Washington, DC, February 2004.
  277. Jones D. Cosmetic Botox in Men. In "Botox Update" course. American Academy of Dermatology Annual Meeting, Washington, DC February 2004.
  278. Jones D. Non-Invasive Facial Rejuvenation. Sponsored by Medicis, as training session for Restylane. Pasadena, CA, January 2004.
  279. Jones D. Results at 1 year in 100 patients treated with liquid injectable silicone for HIV associated lipoatrophy. American Society for Dermatologic Surgery, New Orleans, LA October 2003.
  280. Jones D. Grand Rounds, Department of Dermatology, UCLA. Cosmetic uses of liquid injectable silicone. October 2003.
  281. Jones D. Focus Session: Treatment Options for HIV Associated Lipoatrophy. American Academy of Dermatology Annual Meeting, San Francisco, CA March 2003.
  282. Jones D. Liquid Injectable Silicone, History and Cosmetic Uses. Lecture in Soft Tissue Augmentation Course. American Academy of Dermatology Annual Meeting, San Francisco, CA March 2003.
  283. Jones D. SilSkin for treatment of HIV lipoatrophy. Being Alive symposium for Facial Reconstruction of lipoatrophy. San Diego, CA. November 2002.
  284. Jones, D. Treatment of HIV associated facial lipoatrophy. 3rd Annual International Conference on Adverse Drug Reactions and Lipodystrophy. San Diego, CA. November 2002.
  285. Jones D. Treatment Options for HIV facial Lipoatrophy. Presented at Symposium for Tower Infectious Disease Group, November 12, 2002.
  286. Jones D. Liquid Injectable Silicone for HIV Lipoatrophy. American Society for Dermatologic Surgery Annual Meeting, Chicago, IL October 2002.
  287. Jones D. Treatment options for HIV Associated Lipoatrophy. American Society for Dermatologic Surgery Annual Meeting, Chicago, IL October 2002.
  288. Jones D. Treatment Options for HIV Facial Lipoatrophy. APLA Community Seminar, Los Angeles, CA. August 20, 2002.
  289. Jones D. Temporary Treatment Options for HIV Facial Lipoatrophy. Presented at Forum on HIV Lipoatrophy, AAD Summer Academy, NY, NY August 3, 2002.
  290. Jones D. Grand Rounds, Department of Dermatology, UCLA. Treatment options for HIV associated facial lipoatrophy. July 2002.
  291. Jones D. Fillers for Skin of Color. Defining Skin of Color Symposium, Sponsored by the Skin and Color Institute, Columbia University, New York, New York, June 16, 2002.
  292. Jones D. Treatment Options for Facial Lipoatrophy. Lecture for HIV Matters, sponsored by the Jeffrey Goodman Clinic, Los Angeles, CA, June 11, 2002.
  293. Jones D. Treatment of Facial Lipoatrophy. Lecture in course on Soft Tissue Augmentation, American Academy of Dermatology Annual Meeting, New Orleans, LA. February 2002.
  294. Jones D. Treatment Options for Facial Lipoatrophy. AIDS Healthcare Foundation, Los Angeles Intercity Rounds, Los Angeles, CA, Nov 16, 2001.
  295. Jones D. Treatment of Facial Lipoatrophy. Guest Lecturer, Grand Rounds, UCLA AIDS Institute, Los Angeles, CA, Nov 2, 2001.
  296. Jones D. Cosmetic Problems in the HIV Patient. Guest Lecturer, Grand Rounds, St. Lukes/Roosevelt Affiliated Hospitals, Columbia University, Dept. of Dermatology, NY, NY. Oct 18, 2001.
  297. Jones D. Accutane and the Primary Care Physician. UCLA Student Health CME Lecture Series for Primary Care Providers, June 1999.
  298. Jones D, Treatment of lipodystrophy associated with protease inhibitor therapy. Continuing Education Seminar, AIDS Project Los Angeles, June 1998.
  299. DeMoore GM, Hennessey P, Kunz N, Jones D, Rabkin J. The psychological impact of Kaposi's sarcoma. Poster presentation, International Congress of Dermatology, Sydney, Australia, June 1997.
  300. Jones D. Vesicular cheilitis in association with parvovirus B-19 induced glove and sock purpura. Gross and Microscopic Symposium, 1997 annual meeting of the American Academy of Dermatology, San Francisco, California
  301. Jones D, Kay M, Craigen W, MaCabe E, Hawkins H, Dominey A. Coal black hyperpigmentation at birth in a child with congenital adrenal hypoplasia. Gross and Microscopic Symposium, 1996 annual meeting of the American Academy of Dermatology, Washington, D.C.
  302. Jones D, Perez M. Mucoepidermoid carcinoma of the hard palate resected utilizing Mohs surgery. American College of Mohs Surgery 1996 annual meeting, Palm Desert, California.

Education & Industry

Videos

Video Gallery

See the advanced approaches our Skin Care and Laser Physicians of Beverly Hills team uses to help you Relax, Refill, Resurface, and Reduce. Explore the contributions of Dr. Derek Jones and his team in making some of the most sought-after treatments accessible to the public.

View MoreVideos

Blog

Get "inside" information on a wide range of treatments and procedures available at our practice on our regularly updated blog. We also provide tips and advice for maximizing and prolonging your results to maximize skin health and beauty.

View MoreBlog
Photo Gallery *Patient results may vary.

Photo Gallery

Our photo gallery shows the results that injectables, lasers and light-based treatments, and other cosmetic options can provide. From reducing fat and smoothing wrinkles to minimizing scars from skin cancer removal, take a look at what we can do to help.

View MoreGallery

Media

As an aesthetic and surgical dermatologist trained in Mohs micrographic surgery for skin cancer removal, Dr. Naissan Wesley is a highly sought-after source on the subject of skin. Read her articles and see who's talking about her on her media page.

View MoreMedia

Contact Our Office

SKIN CARE & LASER PHYSICIANS OF BEVERLY HILLS - 9201 W. Sunset Blvd. Suite 602, Los Angeles, CA 90069 US 310.246.0495

Follow us on social media

Stay up to date on the Skin Care & Laser Physicians of Beverly Hills happenings by following us on Facebook, Twitter, Instagram, and more.

security code
Skin Care and Laser Physicians of Beverly Hills

Copyright 2022 Dr. Derek Jones Skin Care and Laser

- 9201 W. Sunset Blvd. Suite 602,
Los Angeles, CA 90069 US

310.246.0495

American Board of Dermatology American Academy of Dermatology American Society for Dermatologic Surgery
HIPAA Privacy Policy Sitemap

Medical Marketing & website design by MetaMed Marketing.

Dr. Derek H. Jones heads Skin Care and Laser Physicians of Beverly Hills, offering aesthetic dermatology, including BOTOX®, Juvéderm®, Kybella™, laser skin resurfacing, and CoolSculpting®, as well as surgical and medical dermatology, including skin cancer, acne, and rosacea treatments, to Los Angeles, Beverly Hills, West Hollywood, and beyond.